avandia
美 
英
例句
The parallels with the Avandia situation are striking, demonstrating the difficulty of trying to assess drug safety issues.
类似的文迪雅事件是惊人的，说明评估药品安全是非常困难的。
Avandia did show a significant advantage in a second measure of artery plaque, but this was not the main result being tested.
文迪雅在动脉斑块的第二个检测项目中的确表现出了明显的优势，但这并不是测试的主要结果。
After Nissen's 2007 study, the FDA added a warning label to Avandia, but decided to leave it on the market.
对尼森2007年的研究结果，FDA还要求文迪雅增加标签警语，但并没有要求其撤市。
FDA advisers said last month the risk appeared real but that the evidence wasn't conclusive enough to merit pulling Avandia from the market.
FDA顾问上个月说，这个危险确实出现，但是将文迪雅撤出市场，证据还不充足。
Avandia has been subjected to repeated trials with different parameters that have had varying outcomes .
文迪雅已接受了反复试验，但由于参数不同，结果各有不同。
Avandia is linked to a greater risk of heart attack and possibly death, reported a new scientific analysis published online Monday.
在星期一的一个新的科学分析中报道：文迪雅可以增加心脏病发作和死亡的危险。
There was Avandia on Monday, Tysabri Tuesday, and acne treatment Accutane yesterday. Are we missing something today?
星期一是文迪雅，星期二是Tysabri，昨天是粉刺药异维甲酸，今天，我们会错过什么么？
Dr. Nissen combined the results of many clinical trials to suggest that Avandia substantially increased heart risks.
尼森先生将许多临床试验的结果结合起来提出文迪雅大大地增加心脏病风险。
The study was funded by the U. S. National Institutes of Health as well as GlaxoSmithKline, which makes Avandia.
该研究由美国国立卫生研究院以及葛兰素史克公司—文迪雅制造商提供资助资金。
The totality of the data show that Avandia has a comparable cardiovascular profile to other oral anti- diabetes medicines .
总体数据显示文迪雅与其它口服抗糖尿病药物在心血管事件方面是相似的。
The issue with Avandia is whether it raises the risk of heart attacks and cardiovascular problems more than other diabetes treatments.
文迪雅的问题在于，与其它的糖尿病治疗方法相比，它引发心脏病及心血管问题的风险是否更大。
Meanwhile, the Houston Chronicle reports, lawyers who specialize in recruiting patients for drug-safety cases have moved on Avandia.
同时根据HoustonChronicle报道，专门代理药物安全性诉讼的律师已经将目标指向文迪雅。
FDA advises health care providers to closely monitor patients who take Avandia for cardiovascular risks.
FDA忠告医保提供者，对服用文迪雅的病人，严密监测心血管的危险。
They did recommend Avandia's label be updated to include information on that risk. The FDA said it was continuing its review of the issue.
他们建议文迪雅的最新的标签，要包括这一危险信息，FDA称，他们将继续关注这一事件。
Since then, prescriptions for Avandia have plunged, although the drug remains on the market.
从那时起，虽然Avandia在市场上依然有售，但它的处方量骤然下降。
Some urged a "black box" warning on Avandia, the strongest type of warning for prescription drugs.
一些专家力促文迪雅标注“黑框警告”——处方药标识中最严重的一种警告。
A. official said that the agency had previously informed doctors about Avandia's heart risks.
负责官员说该机构已经在以前告知了医生们有关Avandia对心脏可能的风险。
So, how are doctors and patients to interpret such widely divergent views on the safety of Avandia?
因此，医生和患者如何理解这些对文迪雅的安全性大相径庭的解释呢？
The misconduct began in the late 1990s and continued, in the case of Avandia's safety data, through to 2007.
这种不当行为始于上世纪九十年代末，在有关罗格列酮的案件上一直持续到2007年。
Now, with a federal panel soon to decide whether it can remain on the market, Avandia's future is uncertain.
预计不久，一个联邦顾问小组将对它是否继续留在市场上销售作出决定，文迪雅的前景难以预料。
The safety controversy has hurt Avandia sales.
安全争议已经对文迪雅销售造成影响。
But in 2007, an analysis of 44 clinical trials of Avandia showed that it could increase heart attacks.
但在2007年，一个对Avandia44个临床试验的分析报告表明它可能增加心脏疾病。
The first posting on a new Web site was about 65 studies involving its popular diabetes drug, Avandia.
在一个新网站的第一个公告是关于广受欢迎的糠尿病药品Avandia的研究报告。
Last week, Europe banned Avandia because of the concern about the risk of myocardial infarction and other cardiovascular risk.
上周，由于担心造成心肌梗塞及其他的心血管风险，欧洲禁止了文迪雅的上市。
There is little sign that the FDA has been slacking on the issue of Avandia.
没有什么迹象显示，FDA在文迪雅问题上工作懈怠。
Sales of Avandia and two related medicines reached $3 billion in 2006.
2006年，Avandia和两个相关药品的销售达到3亿美元。
Did we learn a lesson from Avandia?
我们是否从文迪亚中学到了一课？
The first patents for Avandia expire in 2011, with some running until 2017, according to FDA's Orange Book.
依据FDA的橙皮书，文迪雅第一的专利权将于2011年到期，部分专利权将到2017年。
In 1999, for example, the F. D. A. approved the diabetes drug Avandia on the basis that it reduced blood sugar.
举例来说，1999年，FDA批准了糖尿病药Avandia（文迪雅），依据是它能降低血糖。
Animal studies reported late last year strongly suggest that Actos and Avandia promote bone loss.
近年报道的动物研究强烈地显示艾可拓和文迪雅会促进骨质丢失。
Therapeutic effect observation of avandia combined with glimepiride and metformin in treatment of type 2 diabetes
马来酸罗格列酮联合格列美脲、二甲双胍治疗2型糖尿病的疗效观察
